Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot
Advancements in therapies for Duchenne muscular dystrophy (DMD) have made diagnosis within the newborn period a high priority. We undertook a consortia approach to advance DMD newborn screening in the United States. This manuscript describes the formation of the Duchenne Newborn Screening Consortium...
Main Authors: | Michael J. Hartnett, Michele A. Lloyd-Puryear, Norma P. Tavakoli, Julia Wynn, Carrie L. Koval-Burt, Dorota Gruber, Tracy Trotter, Michele Caggana, Wendy K. Chung, Niki Armstrong, Amy M. Brower |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-515X/8/4/50 |
Similar Items
-
Duchenne and Becker muscular dystrophy in adolescents: current perspectives
by: Andrews JG, et al.
Published: (2018-03-01) -
Molecular characterization and reclassification of a 1.18 Mbp DMD duplication following positive carrier screening for Duchenne/Becker muscular dystrophy
by: Cinthya J. Zepeda‐Mendoza, et al.
Published: (2022-07-01) -
A Roadmap to Newborn Screening for Duchenne Muscular Dystrophy
by: Samiah A. Al-Zaidy, et al.
Published: (2017-04-01) -
Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021-06-01) -
Serum Creatinine Distinguishes Duchenne Muscular Dystrophy from Becker Muscular Dystrophy in Patients Aged ≤3 Years: A Retrospective Study
by: Liang Wang, et al.
Published: (2017-05-01)